ARIEL NEWTON: Open Payments
NPI 1427504539 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,065 in 63 payments from 16 companies in 2025. Trend: 2023 $2,395 · 2024 $2,137 · 2025 $2,065
Food & beverage: $2,065
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $433 |
| Axsome Therapeutics, Inc. | 7 | $349 |
| Dexcom, Inc. | 2 | $206 |
| Vanda Pharmaceuticals Inc. | 8 | $197 |
| Biogen, Inc. | 2 | $142 |
| Otsuka America Pharmaceutical, Inc. | 7 | $139 |
| Neurocrine BioSciences, Inc. | 5 | $139 |
| Lundbeck LLC | 5 | $138 |
| Corium, LLC | 4 | $96 |
| Noven Therapeutics, LLC | 4 | $73 |
Products named: CAPLYTA, Auvelity, REXULTI, Dexcom G6 Transmitter, ZURZUVAE, INGREZZA, FANAPT, Azstarys.
Industry payments across TN — which companies pay providers there.
